ACQUISITION OF CLOSED SYSTEMS FOR ADMINISTRATION AND TRANSFER OF CYTOTOXIC MEDICATIONS IN ONCOLOGY SECTORS - CHEMOLOCK

SANTÉ QUÉBEC - Centre Hospitalier de l'Université de Montréal (CHUM) is undertaking a direct award procurement for the acquisition of closed systems for the administration and transfer of cytotoxic medications, specifically the CHE MOLOCK system, for its oncology sectors. This procurement falls under category G21 - Medical Supplies and Equipment, and Pharmaceuticals; Medical Equipment, Supplies, and Accessories. The contracting authority has justified the use of a direct award contract (Contrat de gré à gré) based on Article 13, Paragraph 4°, citing that a public tender would not serve the public interest. This rationale typically implies a sole-source situation, unique technical requirements, or an urgent need that cannot be met through a competitive bidding process. The CHE MOLOCK system is designed to enhance safety and efficiency in handling hazardous chemotherapy drugs, protecting both healthcare professionals and patients from exposure. The CHUM's decision reflects a commitment to adopting advanced medical technologies to improve patient care and workplace safety within its oncology departments. The specific terms and conditions of this direct award contract will be finalized between SANTÉ QUÉBEC and the selected supplier.

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Medical Equipment and Pharmaceuticals. Located in Canada, North America, this opportunity is open to firms and consortiums.

Published through Quebec SEAO, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.